TickerFactsScreenerDevelopers

Hepion Pharmaceuticals, Inc. (HEPA) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2016: -$16.56M2017: -$19.17M2018: -$15.65M2019: -$7.57M2020: -$16.17M2021: -$31.22M2022: -$34.96M2023: -$40.89M2024: -$18.22M2025: -$3.27M-$3.27M
2016Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$3.27M+82.0%
2024-$18.22M+55.4%
2023-$40.89M-17.0%
2022-$34.96M-12.0%
2021-$31.22M-93.2%
2020-$16.17M-113.7%
2019-$7.57M+51.6%
2018-$15.65M+18.4%
2017-$19.17M-15.8%
2016-$16.56M—